Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 11-12, 2006, Pages 1001-1008

  Lõivukene, Krista ^a   Sepp, Epp ^b   Adamson, Vivika ^a   Mitt, Piret ^a   Kallandi, Ülle ^c   Otter, Karin ^c   Naaber, Paul ^a  

^a TARTU UNIVERSITY CLINICS   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; MEROPENEM; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESTONIA; EUROPEAN UNION; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE BACTERIUM; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ESTONIA; EUROPE; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 33845292926     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540600786507     Document Type: Article

References (19)

1. Weber, DJ and Raasch, R and Rutala, WA. (1999) Nosocomial infections in the ICU. The growing importance of antibiotic-resistance pathogens Chest, 115, pp. 34-41.
2. Canton, R and Coque, TM and Baquero, F. (2003) Multi-resistant Gram-negative bacilli: From epidemics to endemics Curr Opin Infect Dis, 16, pp. 315-25.
3. European Antimicrobial Resistance Surveillance System. Available from: http://www.earss.rivm.nl
4. Murray, RE and Baron, EJ and Jorgensen, JH and Pfaller, MA and Yolken, RH.(2003) Manual of clinical microbiology 8th edn. Washington DC: ASM Press.
5. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically - Sixth Edition: Approved Standard M7-A6. NCCLS, Villanova, PAUSA, 2003.
6. Sörberg, M and Farra, A and Ransjö U and Gårdlund, B and Rylander, M and Settergen, B and (2003) Different trends in antibiotic resistance rates at a university teaching hospital Clin Microbiol Infect, 9, pp. 388-96.
7. Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP. Emerging resistance among bacterial pathogens in the intensive care unit: A European and North American Surveillance study (2000 -2002). Ann Clin MicrobioH Chemother 2004;3:14. Available from: htpp://www.ann-clinmicrobiol.com/content/3/1/14
8. Goossens, H. (2000) MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: Comparison of antibiotic susceptibilities between countries and centre types JAC, 46, pp. 39-52.
9. Lizioli, A and Privitera, G and Alliata, E and Antonietta Banfi, EM and Boselli, L and Panceri, ML and (2003) Prevalence of nosocomial infections in Italy: Result from the Lombardy survey in 2000 J Hosp Infect, 54, pp. 141-8.
10. Meric, M and Willke, A and Caglayan, C and Toker, K. (2005) Intensive care unit-acquired infections: Incidence, risk factors and associated mortality in a Turkish university hospital Jpn J Infect Dis, 58, pp. 297-302.
11. Garcia-Rodriguez JA, Jones RN, MYSTIC Programme Study Group. Antimicrobial resistance in Gram-negative isolates from European intensive care units: Data from yearly susceptibility test information collection (MYSTIC). J Chemother 2002;14:25-32.
12. Frank, U and Jonas, D and Lupke, T and Ribeiro-Ayeh, B and Schmidt-Eisenlohr, E and Ruden, H and (2000) Antimicrobial susceptibility among nosocomial pathogens isolated in intensive care units in Germany Eur J Clin Microbiol Infect Dis., 19, pp. 888-91.
13. Larson, EL. (1981) Persistent carriage of Gram-negative bacteria on hands Am J Infect Control, 9, pp. 112-9.
14. Villers, D and Espaze, E and Coste-Burel, M. (1998) Nosocomial Acinetobacter baumannii infections: Microbiological and clinical epidemiology Ann Intern Med, 129, pp. 182-9.
15. Bergogne-Berezin, E. (2001) Guidelines on antimicrobial chemotherapy for prevention and treatment of infections in the intensive care unit J Chemother, 1, pp. 134-49.
16. Naaber, P and Kõljalg, S and Maimets, M. (2000) Antibiotic usage and resistance trends in Estonian University Hospitals Antimicrob Agents, 16, pp. 309-15.
17. Reynolds, R and Potz, N and Colman, M and Williams, A and Livermore, D and MacGowan, A. (2004) Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001 -2002: The BSAC Bacteraemia Resistance Surveillance Programme JAC, 53, pp. 1018-32.
18. Livermoore, DM and Yuan, M. (1996) Antibiotic resistance and production of ESBL among Klebsiella spp. from intensive care units in Europe JAC, 38, pp. 409-24.
19. Yuce, A and Erdenizmenli, M and Yapar, N and Senger, S and Izmir, TR. (2004) Antibimicrobial resistance of Gram-negative bacilli isolated with bloodstream infections in ICUs Clin Microbiol Infect, 10, pp. 381.